Kairos Pharma KAPA
NYSE KAPA
$0.56 -0.02 (-3.12%)
As of: Oct 22, 2026 · 11:37 AM EDT

Kairos Pharma (KAPA) Liabilities and Shareholders Equity (2023 - 2025)

Updated

Kairos Pharma (KAPA) recorded Liabilities and Shareholders Equity of $6.54 million in Q4 2025, up 13.4% from $5.77 million a year earlier.

Analysis

Kairos Pharma (KAPA) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends

Starting with Q4 2023, Kairos Pharma's Liabilities and Shareholders Equity history includes 6 quarters.

  • Across earlier years, Liabilities and Shareholders Equity came in at $5.77 million in FY2024 (+497.7%) and $965,000 in FY2023.
  • Quarterly Liabilities and Shareholders Equity has ranged from $965,000 in Q4 2023 to $7.94 million in Q1 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn 201.06 Bn
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn 135.12 Bn
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn 201.13 Bn
10 Kairos Pharma 10.29 Mn -2.12 Mn - 6.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.54 Mn
Jun 30, 2025 6.67 Mn
Mar 31, 2025 7.94 Mn
Dec 31, 2024 5.77 Mn
Sep 30, 2024 5.00 Mn
Dec 31, 2023 965,000.00
API Access

Kairos Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KAPA&period=max&api_key=YOUR_API_KEY